Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization-Reference-Cited by-同舟云学术

Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization

Published:2015-10 Issue:10 Volume:26 Page:1472-1478
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Olorunsola Olufoladare G.,Kohi Maureen P.,Behr Spencer C.,Kolli Pallav K.,Taylor Andrew G.,Tong Ricky T.,LaBerge Jeanne M.,Kerlan Robert K.,Fidelman Nicholas

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference15 articles.

1. Technical aspects of radioembolization with 90Y microspheres;Salem;Tech Vasc Interv Radiol,2007

2. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors;Leung;Int J Radiat Oncol Biol Phys,1995

3. Pulmonary radiation injury;Movsas;Chest,1997

4. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications;Murthy;Radiographics,2005

5. Dosimetric considerations in radioimmunotherapy and systemic radionuclide therapies: a review;Loke;World J Nucl Med,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT texture features and lung shunt fraction measured using 99mTc-macroaggregated albumin SPECT/CT before trans-arterial radioembolization for hepatocellular carcinoma patients;Scientific Reports;2023-12-15

2. Non-Invasive Imaging Biomarkers to Predict the Hepatopulmonary Shunt Fraction Before Transarterial Radioembolization in Patients with Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-01

3. Association of dysmorphic intratumoral vessel with high lung shunt fraction in patients with hepatocellular carcinoma;Scientific Reports;2022-08-21

4. Does significantly elevated lung shunt fraction (LSF >20%) promote extrahepatic progression in patients with hepatocellular carcinoma treated with radioembolization?;Nuclear Medicine Communications;2021-03-01

5. Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization;In Vivo;2021